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Chronic respiratory diseases (CRDs) such as asthma and cystic fibrosis represent major global health
challenges and are responsible for >4 million deaths each year.[1] These respiratory diseases are exacerbated
by exposure to allergens, pollutants, particulate matter (PM), and viruses. A major problem is that existing lung
models for testing drug delivery do not represent real human tissues. Thus, there is a need for advanced in vitro
models that can facilitate cellular and molecular research of the respiratory system and potentially serve as a
drug screening platform for drug development. The development of emergent “organ-on-a-chip” technologies
has enabled us to recreate key features of various tissues and organs within engineered microfluidic devices.
However, current microfluidic lung-on-a-chip devices do not recapitulate the mechanobiological effect of airflowinduced shear stress on the epithelial cells of larger airways. Also, the existing devices are only limited to onchip analysis that may hinder the compatibility with existing assessment tools. We have developed a lung-on-achip system referred to as E-FLOAT for airway tissue modelling that is arrayable, scalable, and contains a
removable cell-ladened hydrogel construct capable of withstanding airflow. We also have developed an airflow
system that allows culturing of airway cells under the shear flow to accurately represent the aerodynamic
conditions in the native airways. The E-FLOAT device was fabricated by micro-milling the poly(methyl
methacrylate) (PMMA) plastic layers and bonding the layers via liquid solvent bonding.[2] (Fig 1a) The device
incorporates an anchored suspended hydrogel where we cultured the airway epithelial cells (AECs) under
airflow. The airflow system controls the flow rate, humidity, and temperature of the air for the purpose of
effectively inducing accurate mucociliary differentiation of AECs. In this study, AECs were cultured under three
different conditions: submerged in media, static air-liquid interface (ALI), or with airflow. After experiments, the
hydrogels were extracted for various downstream analyses such as immunostaining, scanning electron
microscopy (SEM) and histology sectioning. Airflow culture showed the most accurate recapitulation of native
airway epithelium. AECs showed high viability and more localized tight junction expression when cultured with
airflow, suggesting that airflow promotes improved barrier function compared to the other two conditions.
Furthermore, the number of mucin-producing goblet cell differentiation with airflow was shown to be more
representative of the native airway epithelium (~10% of epithelial population) (Fig 1b). Also, the AECs cultured
with airflow showed more physiological expression of long cilia (6~7µm), while cells in submerged and ALI
conditions showed shorter microvilli (0.5-1µm) (Fig 1c). Finally, as a demonstration, physiological deposition of
carbon black particulates via airflow was achieved and confirmed by SEM (Fig 1e).
E-FLOAT has unique features that allow for the extraction of the cell-laden hydrogel, providing access to various
analysis tools that are not accessible with other lung-on-a-chip devices. In addition, since it uses a
biocompatible hydrogel, the experiments can be extended to freely add the components that make up for the
airway tissue construct. E-FLOAT has potential to serve as a disease model for CRDs and a drug screening
platform, with potential applications toward understanding nanoparticle toxicity and particular matter exposures
leading to the exacerbation of CRDs.

Figure 1. (a) Photograph of fabricated E-FLOAT device (b) Immunostained AECs cultured under flow
condition. ZO-1 (green); MUC5AC (red); Hoechst (blue). (c) SEM image of AEC cilia expression after being
cultured under airflow. (d) Histology sectioning and H&E staining of the extracted hydrogel. (e) SEM image of
physiological particulate (carbon black) deposition experiment on the airway epithelium.
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